| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1078-0432.CCR-07-1866 |
| P698 | PubMed publication ID | 18212251 |
| P2093 | author name string | Evgeny Edovitsky | |
| Eli Pikarsky | |||
| Michael Elkin | |||
| Tamar Peretz | |||
| Israel Vlodavsky | |||
| Amichay Meirovitz | |||
| Immanuel Lerner | |||
| Leah Baraz | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 668-676 | |
| P577 | publication date | 2008-01-22 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Function of heparanase in prostate tumorigenesis: potential for therapy | |
| P478 | volume | 14 |
| Q42141004 | Altered expression patterns of syndecan-1 and -2 predict biochemical recurrence in prostate cancer. |
| Q37148562 | Berberine Reduces the Metastasis of Chondrosarcoma by Modulating the α v β 3 Integrin and the PKC δ , c-Src, and AP-1 Signaling Pathways |
| Q39259358 | Berberine inhibits the migration and invasion of T24 bladder cancer cells via reducing the expression of heparanase |
| Q33654719 | Conformational changes of 1-4-glucopyranosyl residues of a sulfated C-C linked hexasaccharide |
| Q37380225 | Expression of heparanase in basal cell carcinoma and squamous cell carcinoma |
| Q33634228 | Expression of heparanase in soft tissue sarcomas of adults |
| Q54300601 | Expression of heparanase-1 in prostate gland tumors. |
| Q33747297 | Genetic variations in the heparanase gene (HPSE) associate with increased risk of GVHD following allogeneic stem cell transplantation: effect of discrepancy between recipients and donors |
| Q58705289 | Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression |
| Q36430711 | Heparan sulfate mimetic PG545-mediated antilymphoma effects require TLR9-dependent NK cell activation |
| Q34267974 | Heparanase Enhances Local and Systemic Osteolysis in Multiple Myeloma by Upregulating the Expression and Secretion of RANKL |
| Q34052534 | Heparanase cooperates with Ras to drive breast and skin tumorigenesis |
| Q34289445 | Heparanase enhances myeloma progression via CXCL10 downregulation |
| Q37983752 | Heparanase enzyme in chronic inflammatory bowel disease and colon cancer |
| Q44714576 | Heparanase expression correlates with poor survival in oral mucosal melanoma |
| Q38080632 | Heparanase in inflammation and inflammation-associated cancer |
| Q35838889 | Heparanase induces signal transducer and activator of transcription (STAT) protein phosphorylation: preclinical and clinical significance in head and neck cancer |
| Q37204761 | Heparanase inhibits osteoblastogenesis and shifts bone marrow progenitor cell fate in myeloma bone disease. |
| Q37059154 | Heparanase is overexpressed in lung cancer and correlates inversely with patient survival |
| Q36498218 | Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis |
| Q42587945 | Heparanase: From basic research to therapeutic applications in cancer and inflammation |
| Q38801721 | Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases |
| Q55381084 | Identification of strong intron enhancer in the heparanase gene: effect of functional rs4693608 variant on HPSE enhancer activity in hematological and solid malignancies. |
| Q37562372 | Induction of heparanase by HPV E6 oncogene in head and neck squamous cell carcinoma |
| Q34358383 | Leptin induces oncostatin M production in osteoblasts by downregulating miR-93 through the Akt signaling pathway. |
| Q30244089 | Mechanisms of heparanase inhibitors in cancer therapy |
| Q36413411 | MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9. |
| Q35707564 | Microvessel density and heparanase over-expression in clear cell renal cell cancer: correlations and prognostic significances |
| Q40490330 | PI-88 inhibits postoperative recurrence of hepatocellular carcinoma via disrupting the surge of heparanase after liver resection |
| Q34072292 | Paeonol suppresses chondrosarcoma metastasis through up-regulation of miR-141 by modulating PKCδ and c-Src signaling pathway |
| Q55054468 | Patient derived xenografts (PDX) predict an effective heparanase-based therapy for lung cancer. |
| Q34440769 | Prognostic value of heparanase expression and cellular localization in oral cancer |
| Q90274578 | Prospective Evaluation of Chondroitin Sulfate, Heparan Sulfate and Hyaluronic Acid in Prostate Cancer |
| Q34398151 | Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis |
| Q37986399 | Proteoglycans in prostate cancer |
| Q35836200 | Recent data concerning heparanase: focus on fibrosis, inflammation and cancer |
| Q34762351 | Role of heparanase in radiation-enhanced invasiveness of pancreatic carcinoma |
| Q36101233 | Significance of heparanase in cancer and inflammation |
| Q24605311 | Sulfated hexasaccharides attenuate metastasis by inhibition of P-selectin and heparanase |
| Q37346515 | The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance |
| Q38718475 | The Heparanase Inhibitor PG545 Attenuates Colon Cancer Initiation and Growth, Associating with Increased p21 Expression |
| Q35850606 | The Synthetic Antimicrobial Peptide 19-2.5 Interacts with Heparanase and Heparan Sulfate in Murine and Human Sepsis |
| Q34137792 | Tumorigenic and adhesive properties of heparanase |
| Q33770777 | Versatile role of heparanase in inflammation |
| Q48278219 | Visfatin Promotes IL-6 and TNF-α Production in Human Synovial Fibroblasts by Repressing miR-199a-5p through ERK, p38 and JNK Signaling Pathways. |
Search more.